Trials in Philadelphia, Pennsylvania
Here are the top 10 medical studies for colorectal cancer in Philadelphia, Pennsylvania
Popular Filters
Phase 3 Trials
Chemotherapy
Pump Chemotherapy for Colorectal Cancer
Recruiting2 awardsPhase 3
Philadelphia, Pennsylvania
"This trial is comparing using a special pump to deliver chemotherapy directly to the liver along with regular chemotherapy versus regular chemotherapy alone for patients with colorectal cancer that has spread to the liver and cannot be removed by
PD-1 Inhibitor
Dostarlimab for Colon Cancer
Recruiting2 awardsPhase 3
Wynnewood, Pennsylvania
This trial is testing dostarlimab, a drug that helps the immune system fight cancer. It targets patients with a specific type of colon cancer that has certain genetic features and can be surgically removed. Dostarlimab works by helping the immune system recognize and destroy cancer cells.
Chemotherapy vs Chemoradiotherapy for Rectal Cancer
Recruiting2 awardsPhase 3
Chadds Ford, Pennsylvania
This trial aims to determine if giving chemotherapy alone before limited surgery is as effective as giving chemotherapy and radiation therapy together before surgery in treating rectal cancer. It also seeks to understand if quality of life is
Trials With No Placebo
MAPK Pathway Inhibitor
MRTX0902 + MRTX849 for Solid Tumors
Recruiting1 awardPhase 1 & 2
Baltimore, Maryland
This trial is testing a new drug, MRTX0902, alone and with another drug, adagrasib, in patients with advanced cancers that have specific genetic mutations. The goal is to see if these drugs are safe and can effectively block cancer growth signals. Adagrasib has shown promising results in treating certain types of advanced cancers.
Monoclonal Antibodies
SGN-BB228 for Melanoma
Recruiting1 awardPhase 1
New York, New York
This trial is testing a new drug called SGN-BB228 to see if it can help treat difficult-to-treat cancers like melanoma and other solid tumors. The study will determine the safest amount of the drug to give and check if it works in shrinking or eliminating these tumors. The goal is to find a new treatment option for patients whose cancers are not responding to current therapies.
Monoclonal Antibodies
Combination Immunotherapy for Colorectal Cancer
Recruiting1 awardPhase 2
Brooklyn, New York
This trial is testing two special drugs that help the immune system fight a specific type of cancer. The drugs are given to see if they can shrink the cancer. The study focuses on patients who might not respond well to other treatments. The goal is to see if these drugs are safe and effective.
Antibody-drug conjugate
Vobramitamab Duocarmazine for Prostate Cancer
Recruiting1 awardPhase 2
Baltimore, Maryland
This trial is testing an experimental drug (MGC018) for mCRPC patients who have had prior ARAT and taxane-containing treatment. 150 participants will be randomized 1:1:1 in Phase 2, and 270 will be randomized 1:1 in Phase 3.
View More Related Trials
Frequently Asked Questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the 'trial drug' — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
Is there any support for travel costs?
Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.
Will I know what medication I am taking?
This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.
How long do clinical trials last?
Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.
Do you verify all the trials on your website?
All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.
How quickly will I hear back from a clinical trial?
Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back — in general, verified trials respond to patients within a few days.